Supercharged natural killer cells may hold promise for cancer
A type of ‘supercharged’ immune cell could be mass-produced to help fight cancer. The researchers behind the early-stage finding, from […]
» Read moreMany breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. […] Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are […] PinOctober is Breast Cancer Awareness Month. Of course, you probably already know this: the store shelves are lined with pink […] Non-small-cell lung carcinoma (NSCLC) is often fatal because most cases are not diagnosed until they are so advanced that surgical […] It’s estimated that if Americans adopted a healthier diet, as many as 50 percent of all cancer cases could be […] In the wake of the Nobel Prize in Physiology of Medicine being awarded to James P. Allison and Tasuku Honjo […] (HealthDay)—Exome sequencing-based screening may identify pathogenic and likely pathogenic (P/LP) BRCA1/2 variants that might otherwise remain undetected, according to a […] Dear Mayo Clinic: Is it common to only have a partial thyroidectomy to remove Hurthle cells? My doctor is recommending […] Studies on red and processed meat consumption with breast cancer risk have generated inconsistent results. An International Journal of Cancer […]
New options for breast cancer drug development found in estrogen receptors
Targeted drugs for advanced cancer move from specialist units to community setting
These Products Really Support Breast Cancer Awareness
Novel technology enables detection of early-stage lung cancer when surgical cure still is possible
Cancer Risk Can Be Reduced By Making These Changes To Your Diet
Immunotherapy: ‘Killer’ cells get boost in fight against cancer
Genomic screening can ID undetected BRCA1/2 cancer risk
Q&A: Treatment for Hurthle cell thyroid cancer
Processed meat consumption linked to breast cancer risk